Replies to post #155604 on Anavex Life Sciences Corp (AVXL)

[Amatuer17]

What I am saying is - will AVXL give more details on genetic biomarker in AAIC?
If yes, the scientific community will definitely speak on that - and depending on validity of that biomarker we will see more exposure to the company in news as they could be 1st to identify such bio marker that shows higher drug efficacy in AD
I am not sure if this is genetic biomarker for AD or for drug efficacy.

These discussions itself could give high visibility and push price higher

[bas2020]

It would seem to be a higher percentage just by looking at the percentage of the strong responders who were on the higher dosage. 6 out of 9, perhaps?